Skip to main navigation Skip to search Skip to main content

Fool’s gold? Why blinded trials are not always best

  • Rohan Anand
  • , John Norrie
  • , Judy M Bradley
  • , Danny McAuley
  • , Mike Clarke

Research output: Contribution to journalArticlepeer-review

Abstract

Blinding is intended to reduce bias but can make studies unnecessarily complex or lead to results that no longer address the clinical question
Original languageEnglish
JournalBMJ
DOIs
Publication statusPublished (in print/issue) - 21 Jan 2020

Fingerprint

Dive into the research topics of 'Fool’s gold? Why blinded trials are not always best'. Together they form a unique fingerprint.

Cite this